Drug profile · INN
sulfur hexafluoride lipid-type a microspheres
LUMASON
sulfur hexafluoride lipid-type a microspheres (LUMASON) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — sulfur hexafluoride lipid-type a microspheres
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
sulfur hexafluoride lipid-type a microspheres (LUMASON) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is sulfur hexafluoride lipid-type a microspheres?
sulfur hexafluoride lipid-type a microspheres (LUMASON) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for sulfur hexafluoride lipid-type a microspheres?
LUMASON is a marketed brand name for sulfur hexafluoride lipid-type a microspheres. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sulfur hexafluoride lipid-type a microspheres?
sulfur hexafluoride lipid-type a microspheres has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.